Pentavalent reassortant rotavirus vaccine live vaccine(Vero cell)(Shenzhen Kangtai/Beijing Minhai)

五价重配轮状病毒减毒活疫苗(Vero细胞)(深圳康泰/北京民海)

Report date: 2025/03/28 20:01:04

Base Information

Drug NamePentavalent reassortant rotavirus vaccine live vaccine(Vero cell)(Shenzhen Kangtai/Beijing Minhai)
Drug Alias Name口服五价重配轮状病毒减毒活疫苗（Vero细胞）
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGastroenteritisRotavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShenzhen Kangtai Biological Products Co LtdBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Minhai Biotechnology Co LtdShenzhen Kangtai Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsGastroenteritisRotavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A